Johan Vessby

Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study

Younossi, Zobair M.; De Avila, Leyla; Petta, Salvatore; Hagström, Hannes et al.

Ingår i Hepatology, s. 161-174, 2026

• DOI för Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study

Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study

Younossi, Zobair M.; De Avila, Leyla; Petta, Salvatore; Hagström, Hannes et al.

Ingår i Hepatology, 2026

• DOI för Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study

Metabolic biomarkers add little to diagnostic performance of FIB-4 in MASLD

Ullman, Sofia; Hegmar, Hannes; Vessby, Johan; Nasr, Patrik et al.

Ingår i Scandinavian Journal of Gastroenterology, s. 340-344, 2026

• DOI för Metabolic biomarkers add little to diagnostic performance of FIB-4 in MASLD
• Ladda ner fulltext (pdf) av Metabolic biomarkers add little to diagnostic performance of FIB-4 in MASLD

Reply: Competing risk and surveillance thresholds for HCC in patients with PSC

Holmer, Magnus; Ingre, Michael; Färkkilä, Martti; Ponsioen, Cyriel et al.

Ingår i Hepatology, 2026

• DOI för Reply: Competing risk and surveillance thresholds for HCC in patients with PSC

Cirrhosis and age are key determinants of HCC risk in individuals with primary sclerosing cholangitis: A multicenter longitudinal cohort study

Holmer, Magnus; Ingre, Michael; Färkkilä, Martti; Ponsioen, Cyriel et al.

Ingår i Hepatology, s. 21-29, 2026

• DOI för Cirrhosis and age are key determinants of HCC risk in individuals with primary sclerosing cholangitis: A multicenter longitudinal cohort study
• Ladda ner fulltext (pdf) av Cirrhosis and age are key determinants of HCC risk in individuals with primary sclerosing cholangitis: A multicenter longitudinal cohort study

Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study

Younossi, Zobair M.; De Avila, Leyla; Petta, Salvatore; Hagström, Hannes et al.

Ingår i Hepatology, s. 161-174, 2026

• DOI för Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study

Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study

Younossi, Zobair M.; De Avila, Leyla; Petta, Salvatore; Hagström, Hannes et al.

Ingår i Hepatology, 2026

• DOI för Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study

Metabolic biomarkers add little to diagnostic performance of FIB-4 in MASLD

Ullman, Sofia; Hegmar, Hannes; Vessby, Johan; Nasr, Patrik et al.

Ingår i Scandinavian Journal of Gastroenterology, s. 340-344, 2026

• DOI för Metabolic biomarkers add little to diagnostic performance of FIB-4 in MASLD
• Ladda ner fulltext (pdf) av Metabolic biomarkers add little to diagnostic performance of FIB-4 in MASLD

Reply: Competing risk and surveillance thresholds for HCC in patients with PSC

Holmer, Magnus; Ingre, Michael; Färkkilä, Martti; Ponsioen, Cyriel et al.

Ingår i Hepatology, 2026

• DOI för Reply: Competing risk and surveillance thresholds for HCC in patients with PSC

Cirrhosis and age are key determinants of HCC risk in individuals with primary sclerosing cholangitis: A multicenter longitudinal cohort study

Holmer, Magnus; Ingre, Michael; Färkkilä, Martti; Ponsioen, Cyriel et al.

Ingår i Hepatology, s. 21-29, 2026

• DOI för Cirrhosis and age are key determinants of HCC risk in individuals with primary sclerosing cholangitis: A multicenter longitudinal cohort study
• Ladda ner fulltext (pdf) av Cirrhosis and age are key determinants of HCC risk in individuals with primary sclerosing cholangitis: A multicenter longitudinal cohort study

Characteristics and Clinical Outcomes in Patients With Cirrhosis due to MASLD in Sweden

Shang, Ying; Widman, Linnea; Zhang, Xiao; Fernandes, Gail et al.

Ingår i Liver international, 2026

• DOI för Characteristics and Clinical Outcomes in Patients With Cirrhosis due to MASLD in Sweden
• Ladda ner fulltext (pdf) av Characteristics and Clinical Outcomes in Patients With Cirrhosis due to MASLD in Sweden

Association between invasive and noninvasive liver disease assessments and long-term clinical outcomes in MASLD

Shang, Ying; Vessby, Johan; Kant Mangla, Kamal; Ota, Riku et al.

Ingår i Scandinavian Journal of Gastroenterology, s. 1226-1237, 2025

• DOI för Association between invasive and noninvasive liver disease assessments and long-term clinical outcomes in MASLD
• Ladda ner fulltext (pdf) av Association between invasive and noninvasive liver disease assessments and long-term clinical outcomes in MASLD

Comparison of liver histology and fibrosis-4 scoring as tools for evaluating healthcare resource utilization and costs in patients with MASLD: a Swedish cohort study

Toresson Grip, Emilie; Kant Mangla, Kamal; Ota, Riku; Künkel Winther, Marc et al.

Ingår i Scandinavian Journal of Gastroenterology, s. 1104-1119, 2025

• DOI för Comparison of liver histology and fibrosis-4 scoring as tools for evaluating healthcare resource utilization and costs in patients with MASLD: a Swedish cohort study
• Ladda ner fulltext (pdf) av Comparison of liver histology and fibrosis-4 scoring as tools for evaluating healthcare resource utilization and costs in patients with MASLD: a Swedish cohort study

Effects of an anti-lipogenic low-carbohydrate high polyunsaturated fat diet or a healthy Nordic diet versus usual care on liver fat and cardiometabolic disorders in type 2 diabetes or prediabetes: a randomized controlled trial (NAFLDiet)

Fridén, Michael; Rosqvist, Fredrik; Kullberg, Joel; Berglund, Lars et al.

Ingår i Nature Communications, 2025

• DOI för Effects of an anti-lipogenic low-carbohydrate high polyunsaturated fat diet or a healthy Nordic diet versus usual care on liver fat and cardiometabolic disorders in type 2 diabetes or prediabetes: a randomized controlled trial (NAFLDiet)
• Ladda ner fulltext (pdf) av Effects of an anti-lipogenic low-carbohydrate high polyunsaturated fat diet or a healthy Nordic diet versus usual care on liver fat and cardiometabolic disorders in type 2 diabetes or prediabetes: a randomized controlled trial (NAFLDiet)

Proteomic signatures for fibrosis in MASLD: a biopsy-proven dual-cohort study

Blomdahl, Julia; Åberg, Mikael; Fridén, Michael; Ahlström, Håkan et al.

Ingår i Scandinavian Journal of Gastroenterology, s. 597-605, 2025

• DOI för Proteomic signatures for fibrosis in MASLD: a biopsy-proven dual-cohort study
• Ladda ner fulltext (pdf) av Proteomic signatures for fibrosis in MASLD: a biopsy-proven dual-cohort study

Determinants of divergent Salmonella and Shigella epithelial colonization strategies resolved in human enteroids and colonoids

Geiser, Petra; Di Martino, Maria Letizia; Lopes, Ana C. C.; Bergholtz, Alexandra et al.

Ingår i mBio, s. 1-22, 2025

• DOI för Determinants of divergent Salmonella and Shigella epithelial colonization strategies resolved in human enteroids and colonoids
• Ladda ner fulltext (pdf) av Determinants of divergent Salmonella and Shigella epithelial colonization strategies resolved in human enteroids and colonoids

Association between longitudinal biomarkers and major adverse liver outcomes in patients with non-cirrhotic metabolic dysfunction-associated steatotic liver disease

Shang, Ying; Akbari, Camilla; Dodd, Maja; Zhang, Xiao et al.

Ingår i Hepatology, s. 1501-1511, 2025

• DOI för Association between longitudinal biomarkers and major adverse liver outcomes in patients with non-cirrhotic metabolic dysfunction-associated steatotic liver disease

Cause of death by fibrosis stage in 959 patients with biopsy-proven NAFLD

Shang, Ying; Akbari, Camilla; Dodd, Maja; Nasr, Patrik et al.

Ingår i Gut, 2024

• DOI för Cause of death by fibrosis stage in 959 patients with biopsy-proven NAFLD

Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD

Yang, Wen; Ebrahimi, Fahim; Romeo, Stefano; Holmer, Magnus et al.

Ingår i Liver international, s. 1253-1264, 2024

• DOI för Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD
• Ladda ner fulltext (pdf) av Risk of major adverse liver outcomes among first-degree relatives of individuals with MASLD

Liver stiffness predicts progression to liver-related events in patients with chronic liver disease: A cohort study of 14 414 patients

Hegmar, Hannes; Wester, Axel; Aleman, Soo; Backman, Jens et al.

Ingår i Liver international, s. 1689-1699, 2024

• DOI för Liver stiffness predicts progression to liver-related events in patients with chronic liver disease: A cohort study of 14 414 patients
• Ladda ner fulltext (pdf) av Liver stiffness predicts progression to liver-related events in patients with chronic liver disease: A cohort study of 14 414 patients

Performance of novel collagen turnover biomarkers to detect increased liver stiffness in MASLD

Hegmar, Hannes; Wiggers, Thomas; Nasr, Patrik; Vessby, Johan et al.

Ingår i Journal of Internal Medicine, s. 177-186, 2024

• DOI för Performance of novel collagen turnover biomarkers to detect increased liver stiffness in MASLD
• Ladda ner fulltext (pdf) av Performance of novel collagen turnover biomarkers to detect increased liver stiffness in MASLD

99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical

Hagström, Hannes; Vessby, Johan; Ekstedt, Mattias; Shang, Ying

Ingår i Journal of Hepatology, 2024

• DOI för 99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical

Substitutions of saturated fat intakes with other macronutrients and foods and risk of NAFLD cirrhosis and all-cause hepatocellular carcinoma: a prospective cohort study

Fridén, Michael; Warensjö Lemming, Eva; Lind, Lars; Vessby, Johan et al.

Ingår i American Journal of Clinical Nutrition, s. 187-195, 2024

• DOI för Substitutions of saturated fat intakes with other macronutrients and foods and risk of NAFLD cirrhosis and all-cause hepatocellular carcinoma: a prospective cohort study
• Ladda ner fulltext (pdf) av Substitutions of saturated fat intakes with other macronutrients and foods and risk of NAFLD cirrhosis and all-cause hepatocellular carcinoma: a prospective cohort study

Reply to P Yang et al

Fridén, Michael; Warensjö Lemming, Eva; Lind, Lars; Vessby, Johan et al.

Ingår i American Journal of Clinical Nutrition, s. 985-986, 2024

• DOI för Reply to P Yang et al

Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD

Akbari, Camilla; Dodd, Maja; Stål, Per; Nasr, Patrik et al.

Ingår i JHEP Reports, 2024

• DOI för Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD
• Ladda ner fulltext (pdf) av Long-term major adverse liver outcomes in 1,260 patients with non-cirrhotic NAFLD

An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography

Liang, Jia-xu; Ampuero, Javier; Niu, Hao; Imajo, Kento et al.

Ingår i Journal of Hepatology, s. 592-604, 2023

• DOI för An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography
• Ladda ner fulltext (pdf) av An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography

Peritumoral portal enhancement during transarterial chemoembolization: a potential prognostic factor for patients with hepatocellular carcinoma.

Sennefelt Nyman, Sofi; Dimopoulou, Angeliki; Johnson, Ulf; Rorsman, Fredrik et al.

Ingår i Acta Radiologica, s. 1323-1331, 2022

• DOI för Peritumoral portal enhancement during transarterial chemoembolization: a potential prognostic factor for patients with hepatocellular carcinoma.
• Ladda ner fulltext (pdf) av Peritumoral portal enhancement during transarterial chemoembolization: a potential prognostic factor for patients with hepatocellular carcinoma.

Hepatic Unsaturated Fatty Acids Are Linked to Lower Degree of Fibrosis in Non-alcoholic Fatty Liver Disease

Fridén, Michael; Rosqvist, Fredrik; Ahlström, Håkan; Niessen, Heiko G. et al.

Ingår i Frontiers in Medicine, 2022

• DOI för Hepatic Unsaturated Fatty Acids Are Linked to Lower Degree of Fibrosis in Non-alcoholic Fatty Liver Disease
• Ladda ner fulltext (pdf) av Hepatic Unsaturated Fatty Acids Are Linked to Lower Degree of Fibrosis in Non-alcoholic Fatty Liver Disease

Fatty acids in multiple circulating lipid fractions reflects the composition of liver triglycerides in humans

Rosqvist, Fredrik; Fridén, Michael; Vessby, Johan; Hockings, Paul et al.

Ingår i Clinical Nutrition, s. 805-809, 2022

• DOI för Fatty acids in multiple circulating lipid fractions reflects the composition of liver triglycerides in humans
• Ladda ner fulltext (pdf) av Fatty acids in multiple circulating lipid fractions reflects the composition of liver triglycerides in humans

Circulating fatty acids from high-throughput metabolomics platforms as potential biomarkers of dietary fatty acids

Rosqvist, Fredrik; Fridén, Michael; Vessby, Johan; Rorsman, Fredrik et al.

Ingår i Clinical Nutrition, s. 2637-2643, 2022

• DOI för Circulating fatty acids from high-throughput metabolomics platforms as potential biomarkers of dietary fatty acids
• Ladda ner fulltext (pdf) av Circulating fatty acids from high-throughput metabolomics platforms as potential biomarkers of dietary fatty acids

AGPAT1 as a Novel Colonic Biomarker for Discriminating Between Ulcerative Colitis With and Without Primary Sclerosing Cholangitis

Vessby, Johan; Wisniewski, Jacek R.; Lindskog, Cecilia; Eriksson, Niclas et al.

Ingår i Clinical and Translational Gastroenterology, 2022

• DOI för AGPAT1 as a Novel Colonic Biomarker for Discriminating Between Ulcerative Colitis With and Without Primary Sclerosing Cholangitis

Placement of a transjugular intrahepatic portosystemic shunt in addition to recanalization of acute and chronic portomesenteric vein occlusions: a retrospective evaluation

Ebeling Barbier, Charlotte; Rorsman, Fredrik; Eriksson, Lars-Gunnar; Sangfelt, Per et al.

Ingår i Acta Radiologica, Supplement, 2020

• DOI för Placement of a transjugular intrahepatic portosystemic shunt in addition to recanalization of acute and chronic portomesenteric vein occlusions: a retrospective evaluation
• Ladda ner fulltext (pdf) av Placement of a transjugular intrahepatic portosystemic shunt in addition to recanalization of acute and chronic portomesenteric vein occlusions: a retrospective evaluation

High serum sCD40 and a distinct colonic T cell profile in ulcerative colitis associated with primary sclerosing cholangitis.

Lampinen, Maria; Vessby, Johan; Fredricsson, Annika; Wanders, Alkwin et al.

Ingår i Journal of Crohn's & Colitis, s. 341-350, 2019

• DOI för High serum sCD40 and a distinct colonic T cell profile in ulcerative colitis associated with primary sclerosing cholangitis.

Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis.

Vessby, Johan; Lampinen, Maria; Åberg, Mikael; Rorsman, Fredrik et al.

Ingår i Upsala Journal of Medical Sciences, s. 238-245, 2019

• DOI för Tissue factor in ulcerative colitis, with and without concomitant primary sclerosing cholangitis.

Downregulated eosinophil activity in ulcerative colitis with concomitant primary sclerosing cholangitis

Lampinen, Maria; Fredricsson, Annika; Vessby, Johan; Martinez, Johana Fernandez et al.

Ingår i Journal of Leukocyte Biology, s. 173-183, 2018

• DOI för Downregulated eosinophil activity in ulcerative colitis with concomitant primary sclerosing cholangitis

Expression of the liver homing receptor CXCR3+on colonic CD8+T lymphocytes in patients with primary sclerosing cholangitis provides a possible link between colonic and biliary duct inflammation

Lampinen, Maria; Fredricsson, Annika; Vessby, Johan; Wanders, A. et al.

Ingår i Journal of Crohn's & Colitis, 2016

Type 1 diabetes is associated with increased cyclooxygenase- and cytokine-mediated inflammation

Basu, Samar; Larsson, Anders; Vessby, Johan; Vessby, Bengt et al.

Ingår i Diabetes Care, s. 1371-1375, 2005

• DOI för Type 1 diabetes is associated with increased cyclooxygenase- and cytokine-mediated inflammation

Oxidative stress and antioxidant status in type 1 diabetes mellitus

Vessby, Johan; Basu, Samar; Mohsen, R.; Berne, Christian et al.

Ingår i Journal of Internal Medicine, s. 69-76, 2002

• DOI för Oxidative stress and antioxidant status in type 1 diabetes mellitus

Studies of ulcerative colitis with concomitant primary sclerosing cholangitis: Beyond the clinical phenotype

Vessby, Johan

2020

• Ladda ner fulltext (pdf) av Studies of ulcerative colitis with concomitant primary sclerosing cholangitis: Beyond the clinical phenotype

A two-step proteomic approach identifies candidate biomarker in ulcerative colitis with concomitant primary sclerosing cholangitis.

Vessby, Johan; Wisniewski, Jacek; Eriksson, Niclas; Gabrysch, Katja et al.